Found 8 matching trials
Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment
PHASE4A potential application of therapeutic drug monitoring is to predict effica...
Location
Sint Maartenskliniek
Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.
N/AHLA-DQA1\*05 variant carriers are at risk of developing antibodies against ...
Location
Hospital Universitario Rio Hortega
Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
PHASE4Rheumatoid arthritis (RA) is the most common inflammatory joint disorder. S...
Location
Infirmerie Protestante
Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
N/AThis study is to assess standardized Adalimumab (ADA) concentrations in Ped...
Location
University Children's Hospital Tubingen
Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
N/ADrug serum concentrations will be measured at several time-points for infla...
Location
Rikshospitalet-Radiumhospitalet HF, Oslo University Hospital
Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
NACurrent standard of care of rheumatoid arthritis (RA) management includes a...
Location
Boston Medical Center, Rheumatology Clinic
Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
N/AObservational pharmacokinetics study of adalimumab in patients with active ...
Location
University Hospitals Leuven
Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring
PHASE4Several prior studies have shown that dose reduction of Tumor Necrosis Fact...
Location
Reade Rheumatology Research Institute